Fred Hutchinson Cancer Research Center and NSB Postech have reached a collaboration agreement to coordinate their efforts and to determine the efficacy of the NSB's NanoCones surface technology in creating high quality proteomic microarrays, to be used in the study of human diseases.
Subscribe to our email newsletter
This collaboration will involve a comparison of slides created with NSB’s newly developed NanoCones surface technology and the current industry standard. NSB has agreed to fund the collaboration.
Paul Lampe, member of the Hutchinson Center’s Public Health Sciences Division, said: “We are excited about the preliminary data that has been generated when antibodies were arrayed using the NanoCones technology. We hope this will make our antibody arrays more sensitive and accurate.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.